Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma

Lauren E. Abrey, Tracy T. Batchelor, Andrés J.M. Ferreri, Mary Gospodarowicz, Elisa J. Pulczynski, Emanuele Zucca, Justine R. Smith, Agnieszka Korfel, Carole Soussain, Lisa M. DeAngelis, Edward A. Neuwelt, Brian Patrick O'Neill, Eckhard Thiel, Tamara Shenkier, Fransesc Graus, Martin van den Bent, John F. Seymour, Philip Poortmans, James Olen Armitage, Franco Cavalli

Research output: Contribution to journalReview article

397 Citations (Scopus)

Abstract

Standardized guidelines for the baseline evaluation and response assessment of primary CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly diagnosed patients. The relative rarity of this tumor precludes rapid completion of large-scale phase III trials and, therefore, our reliance on the results of well-designed phase II trials is critical. To formulate this recommendation, an international group of experts representing hematologic oncology, medical oncology, neuro-oncology, neurology, radiation oncology, neurosurgery, and ophthalmology met to review current standards of reporting and to formulate a consensus opinion regarding minimum baseline evaluation and common standards for assessing response to therapy. The response guidelines were based on the results of neuroimaging, corticosteroid use, ophthalmologic examination, and CSF cytology. A critical issue that requires additional study is the optimal method to assess the neurocognitive impact of therapy and address the quality of life of PCNSL survivors. We hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow us to develop better therapies for patients.

Original languageEnglish (US)
Pages (from-to)5034-5043
Number of pages10
JournalJournal of Clinical Oncology
Volume23
Issue number22
DOIs
StatePublished - Dec 1 2005

Fingerprint

Lymphoma
Guidelines
Education
Clinical Trials
Radiation Oncology
Medical Oncology
Neurosurgery
Ophthalmology
Neurology
Neuroimaging
Cell Biology
Survivors
Consensus
Adrenal Cortex Hormones
Therapeutics
Communication
Quality of Life
Research Personnel
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Abrey, L. E., Batchelor, T. T., Ferreri, A. J. M., Gospodarowicz, M., Pulczynski, E. J., Zucca, E., ... Cavalli, F. (2005). Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. Journal of Clinical Oncology, 23(22), 5034-5043. https://doi.org/10.1200/JCO.2005.13.524

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. / Abrey, Lauren E.; Batchelor, Tracy T.; Ferreri, Andrés J.M.; Gospodarowicz, Mary; Pulczynski, Elisa J.; Zucca, Emanuele; Smith, Justine R.; Korfel, Agnieszka; Soussain, Carole; DeAngelis, Lisa M.; Neuwelt, Edward A.; O'Neill, Brian Patrick; Thiel, Eckhard; Shenkier, Tamara; Graus, Fransesc; van den Bent, Martin; Seymour, John F.; Poortmans, Philip; Armitage, James Olen; Cavalli, Franco.

In: Journal of Clinical Oncology, Vol. 23, No. 22, 01.12.2005, p. 5034-5043.

Research output: Contribution to journalReview article

Abrey, LE, Batchelor, TT, Ferreri, AJM, Gospodarowicz, M, Pulczynski, EJ, Zucca, E, Smith, JR, Korfel, A, Soussain, C, DeAngelis, LM, Neuwelt, EA, O'Neill, BP, Thiel, E, Shenkier, T, Graus, F, van den Bent, M, Seymour, JF, Poortmans, P, Armitage, JO & Cavalli, F 2005, 'Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma', Journal of Clinical Oncology, vol. 23, no. 22, pp. 5034-5043. https://doi.org/10.1200/JCO.2005.13.524
Abrey, Lauren E. ; Batchelor, Tracy T. ; Ferreri, Andrés J.M. ; Gospodarowicz, Mary ; Pulczynski, Elisa J. ; Zucca, Emanuele ; Smith, Justine R. ; Korfel, Agnieszka ; Soussain, Carole ; DeAngelis, Lisa M. ; Neuwelt, Edward A. ; O'Neill, Brian Patrick ; Thiel, Eckhard ; Shenkier, Tamara ; Graus, Fransesc ; van den Bent, Martin ; Seymour, John F. ; Poortmans, Philip ; Armitage, James Olen ; Cavalli, Franco. / Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. In: Journal of Clinical Oncology. 2005 ; Vol. 23, No. 22. pp. 5034-5043.
@article{1d317e1584314566aff915fbaa8f44a1,
title = "Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma",
abstract = "Standardized guidelines for the baseline evaluation and response assessment of primary CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly diagnosed patients. The relative rarity of this tumor precludes rapid completion of large-scale phase III trials and, therefore, our reliance on the results of well-designed phase II trials is critical. To formulate this recommendation, an international group of experts representing hematologic oncology, medical oncology, neuro-oncology, neurology, radiation oncology, neurosurgery, and ophthalmology met to review current standards of reporting and to formulate a consensus opinion regarding minimum baseline evaluation and common standards for assessing response to therapy. The response guidelines were based on the results of neuroimaging, corticosteroid use, ophthalmologic examination, and CSF cytology. A critical issue that requires additional study is the optimal method to assess the neurocognitive impact of therapy and address the quality of life of PCNSL survivors. We hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow us to develop better therapies for patients.",
author = "Abrey, {Lauren E.} and Batchelor, {Tracy T.} and Ferreri, {Andr{\'e}s J.M.} and Mary Gospodarowicz and Pulczynski, {Elisa J.} and Emanuele Zucca and Smith, {Justine R.} and Agnieszka Korfel and Carole Soussain and DeAngelis, {Lisa M.} and Neuwelt, {Edward A.} and O'Neill, {Brian Patrick} and Eckhard Thiel and Tamara Shenkier and Fransesc Graus and {van den Bent}, Martin and Seymour, {John F.} and Philip Poortmans and Armitage, {James Olen} and Franco Cavalli",
year = "2005",
month = "12",
day = "1",
doi = "10.1200/JCO.2005.13.524",
language = "English (US)",
volume = "23",
pages = "5034--5043",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "22",

}

TY - JOUR

T1 - Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma

AU - Abrey, Lauren E.

AU - Batchelor, Tracy T.

AU - Ferreri, Andrés J.M.

AU - Gospodarowicz, Mary

AU - Pulczynski, Elisa J.

AU - Zucca, Emanuele

AU - Smith, Justine R.

AU - Korfel, Agnieszka

AU - Soussain, Carole

AU - DeAngelis, Lisa M.

AU - Neuwelt, Edward A.

AU - O'Neill, Brian Patrick

AU - Thiel, Eckhard

AU - Shenkier, Tamara

AU - Graus, Fransesc

AU - van den Bent, Martin

AU - Seymour, John F.

AU - Poortmans, Philip

AU - Armitage, James Olen

AU - Cavalli, Franco

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Standardized guidelines for the baseline evaluation and response assessment of primary CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly diagnosed patients. The relative rarity of this tumor precludes rapid completion of large-scale phase III trials and, therefore, our reliance on the results of well-designed phase II trials is critical. To formulate this recommendation, an international group of experts representing hematologic oncology, medical oncology, neuro-oncology, neurology, radiation oncology, neurosurgery, and ophthalmology met to review current standards of reporting and to formulate a consensus opinion regarding minimum baseline evaluation and common standards for assessing response to therapy. The response guidelines were based on the results of neuroimaging, corticosteroid use, ophthalmologic examination, and CSF cytology. A critical issue that requires additional study is the optimal method to assess the neurocognitive impact of therapy and address the quality of life of PCNSL survivors. We hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow us to develop better therapies for patients.

AB - Standardized guidelines for the baseline evaluation and response assessment of primary CNS lymphoma (PCNSL) are critical to ensure comparability among clinical trials for newly diagnosed patients. The relative rarity of this tumor precludes rapid completion of large-scale phase III trials and, therefore, our reliance on the results of well-designed phase II trials is critical. To formulate this recommendation, an international group of experts representing hematologic oncology, medical oncology, neuro-oncology, neurology, radiation oncology, neurosurgery, and ophthalmology met to review current standards of reporting and to formulate a consensus opinion regarding minimum baseline evaluation and common standards for assessing response to therapy. The response guidelines were based on the results of neuroimaging, corticosteroid use, ophthalmologic examination, and CSF cytology. A critical issue that requires additional study is the optimal method to assess the neurocognitive impact of therapy and address the quality of life of PCNSL survivors. We hope that these guidelines will improve communication among investigators and comparability among clinical trials in a way that will allow us to develop better therapies for patients.

UR - http://www.scopus.com/inward/record.url?scp=24644432553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24644432553&partnerID=8YFLogxK

U2 - 10.1200/JCO.2005.13.524

DO - 10.1200/JCO.2005.13.524

M3 - Review article

VL - 23

SP - 5034

EP - 5043

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 22

ER -